Denmark's Octarine Bio has raised €5M ($5.8M) in new funding to launch precision-fermented pigments for food, textiles, and ...

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...

Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj Precision ...

Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...